References
- Akinwunmi, B., Buchenberger, D., Scherzer, J., Bode, M., Rizzini, P., Vecchio, F., Roustand, L., Nachbaur, G., Finkielsztejn, L., Chounta, V., & Van de Velde, N. (2021). Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe. European Journal of Public Health. https://doi.org/https://doi.org/10.1093/eurpub/ckaa229
- Bhosle, M., Benner, J. S., Dekoven, M., & Shelton, J. (2009). Difficult to swallow: Patient preferences for alternative valproate pharmaceutical formulations. Patient Preference and Adherence, 3, 161–171. https://doi.org/https://doi.org/10.2147/PPA.S5691. https://www.ncbi.nlm.nih.gov/pubmed/19936158
- de Argila, C. M., Ponce, J., Márquez, E., Plazas, M. J., Galván, J., Heras, J., & Porcel, J. (2007). Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease: ACEPTO study. Clinical Drug Investigation, 27(11), 765–770. https://doi.org/https://doi.org/10.2165/00044011-200727110-00003
- Fields, J., Go, J. T., & Schulze, K. S. (2015). Pill properties that cause dysphagia and treatment failure. Current Therapeutic Research, 77, 79–82. https://doi.org/https://doi.org/10.1016/j.curtheres.2015.08.002. https://www.ncbi.nlm.nih.gov/pubmed/26543509
- Gallant, J., Lazzarin, A., Mills, A., Orkin, C., Podzamczer, D., Tebas, P., Girard, P.-M., Brar, I., Daar, E. S., Wohl, D., Rockstroh, J., Wei, X., Custodio, J., White, K., Martin, H., Cheng, A., & Quirk, E. (2017). Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): A double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. The Lancet, 390(10107), 2063–2072. https://doi.org/https://doi.org/10.1016/S0140-6736(17)32299-7. https://www.ncbi.nlm.nih.gov/pubmed/28867497
- Kakuda, T. N., Berckmans, C., Smedt, G. D., Leemans, R., Leopold, L., Peeters, M., Nijs, S., Vyncke, V., Solingen-Ristea, R. v., & Hoetelmans, R. M. W. (2013). Single-dose pharmacokinetics of pediatric and adult formulations of etravirine and swallowability of the 200-mg tablet: Results from three phase 1 studies. International Journal of Clinical Pharmacology and Therapeutics, 51(9), 725–737. https://doi.org/https://doi.org/10.5414/CP201770. https://www.ncbi.nlm.nih.gov/pubmed/23924679
- Nausieda, P. A., Pfeiffer, R. F., Tagliati, M., Kastenholz, K. V., DeRoche, C., & Slevin, J. T. (2005). A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Clinical Therapeutics, 27(1), 58–63. https://doi.org/https://doi.org/10.1016/j.clinthera.2005.01.004. https://www.ncbi.nlm.nih.gov/pubmed/15763606
- Schiele, J. T., Quinzler, R., Klimm, H. D., Pruszydlo, M. G., & Haefeli, W. E. (2013). Difficulties swallowing solid oral dosage forms in a general practice population: Prevalence, causes, and relationship to dosage forms. European Journal of Clinical Pharmacology, 69(4), 937–948. https://doi.org/https://doi.org/10.1007/s00228-012-1417-0. https://www.ncbi.nlm.nih.gov/pubmed/23052416
- Singh, J. A. (2014). Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: A qualitative study. Arthritis Research & Therapy, 16(2), R82. https://doi.org/https://doi.org/10.1186/ar4524. https://www.ncbi.nlm.nih.gov/pubmed/24678765
- US Department of Health and Human Services Food and Drug Administration, & Center for Drug Evaluation and Research. (2015). Size, shape, and other physical attributes of generic tablets and capsules. Guidance for industry. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm
- World Health Organization. (2014). 90-90-90 an ambitious treatment target to help end the AIDS epidemic. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
- World Health Organization. (2020a). Consolidated HIV strategic information guidelines driving impact through programme monitoring and management.
- World Health Organization. (2020b, September 14). HIV/AIDS data and statistics. https://www.who.int/hiv/data/en/